Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Get coverage of the latest pharmaceutical business developments, and historical metrics on financing, licensing, partnership, and acquisition.
Our trusted Pharma Intelligence brands
Pink Sheet
By Cathy Kelly 15 Jun 2019
Reform "is going to happen,” promised Energy & Commerce Oversight Subcommittee Chair Diana DeGette, suggesting the panel’s next hearing on insulin price reform may be held in July.
Topic Diabetes
Scrip
By Jung Won Shin 15 Jun 2019
2019 could be a monumental year for the South Korean pharma industry, as several new drug assets await the green light from the US FDA.
Topic FDA Business strategies
Datamonitor Healthcare
15 Jun 2019
Informa Pharma Intelligence is marking Depression Awareness Month with a free download of Depression Disease Market and Forecast Analysis 2024. Download your free extract from this vital report and tap into the exclusive data and insights into the depression market available only from the experts at Datamonitor Healthcare, part of the Informa Pharma Intelligence suite of tools.
Datamonitor Healthcare
15 Jun 2019
In recognition of World Heart Day, September 29, 2018, Informa Pharma Intelligence would like to invite you to download our latest whitepaper, Better Heart Health with Mobile Apps? The Impact of Mobile Apps on Coronary Heart Disease in the US. This exploration into the results of a recent analysis of the US Behavioral Risk Factor Surveillance System (BRFSS), coupled with an analysis of several health apps targeting coronary heart disease (CHD) and other heart disease factors, is available to you now – for free.
Scrip
By Jung Won Shin 15 Jun 2019
South Korean financial authorities conclude Samsung BioLogics violated accounting standards by omitting certain information on its joint venture agreement with Biogen from public disclosures, and have ordered further investigation of a corporate governance decision on the handling in accounts of the JV, Samsung Bioepis. The latest ruling in the prolonged affair could hurt the credibility and business of Samsung BioLogics going forward, although the firm maintains it has done nothing improper.
Topic Policy and regulation
Scrip
By Jung Won Shin 15 Jun 2019
Application of artificial intelligence to new drug development in South Korea, which has been lagging in this area, is poised to accelerate as the country moves to support and encourage the technology.
Pink Sheet
By Ferdous Al-Faruque 15 Jun 2019
As the partial US government shutdown enters its second month, the backlog of device pre-market applications is building. AdvaMed is proposing language that would allow FDA to accept and review new user-fee-funded submissions during government shutdowns.
Topic US Shutdown FDA
Primal Pictures
15 Jun 2019
This whitepaper explores how best in class anatomy, physiology and clinical content, images and customized solutions enable organizations to achieve strong competitive advantage, drive credibility, productivity and differentiation. We will share ideas that you can consistently apply to your own organization to reach business and revenue goals. Finally, we will conclude with a checklist of what to look for when selecting your anatomy content solution.
Trialtrove
By Doro Shin 15 Jun 2019
For a detailed look at the statistics and trends surrounding clinical trials initiated in 2017, we invite you to download 2017 Clinical Trials Roundup: The Evolution Continues. Using a wealth of trial data from Trialtrove, this information-packed white paper provides a detailed analysis of Phase I–III clinical trials that were initiated last year.
Topic Clinical trials
HBW Insight
By Ryan Nelson 13 Jun 2019
The Cosmetic Ingredient Review’s newly figured margins of safety for single- and multi-paraben use in cosmetic products are dramatically lower than previous MOSs that informed the Expert Panel’s 2008 “safe as used” conclusions. Whether the panel still deems the MOSs sufficiently protective is the question going into the group’s Sept. 24-25 meeting.
Medtech Insight
By Ferdous Al-Faruque 13 Jun 2019
CVRx CEO Nadim Yared has moved up on the board of directors at the Medical Device Innovation Consortium as its new chair. The public-private partnership group that formed in 2012 has been effective in working with the US Food and Drug Administration to develop new regulations.
Medtech Insight
By Ferdous Al-Faruque 13 Jun 2019
US regulators are proposing makers of fertility assistant devices first test their products on mice embryos in the lab to better understand any potential toxicity risk to human embryos and the viability of the fetus.
Topic FDA Policy and regulation
Datamonitor Healthcare
13 Jun 2019
Disease management and treatment programmes change, as research evolves and new discoveries are made. Your market access strategies must evolve too.
Scrip
By Kevin Grogan 13 Jun 2019
Novartis’s erstwhile head of pharma will be tasked with making the French drug maker more agile on the commercial and research fronts and expanding its digital capabilities.
Topic Business strategies Strategy
Scrip
By Sten Stovall 13 Jun 2019
Vaccine maker Sanofi Pasteur and managed care group Kaiser Permanente have joined forces in an observational trial using electronic medical records from 1.6 million people to highlight the benefits of integrated big data.
Scrip
18 Jun 2019
Scrip
18 Jun 2019
Medtech Insight
18 Jun 2019
Pink Sheet
17 Jun 2019
In Vivo
17 Jun 2019
Scrip
17 Jun 2019
Scrip
17 Jun 2019
Pink Sheet
17 Jun 2019
Scrip
17 Jun 2019
Scrip
17 Jun 2019
In Vivo
17 Jun 2019
Scrip
17 Jun 2019
Pink Sheet
17 Jun 2019
Pink Sheet
17 Jun 2019
Pink Sheet
17 Jun 2019
Trialtrove is the go-to resource for clinical trial research. Easily track your competitors' clinical R&D activity with expert insights and continually monitored trials.
Key benefits:
Datamonitor Healthcare's expert coverage of key diseases, companies, drugs and market trends makes it the go-to product for pharmaceutical and biotechnology companies to support the development and validation of their strategic plans and commercial decisions.
Key benefits:
Key benefits:
23 Jun 2019 , 08:00 PST
California , USA
Industry conference
01 Jul 2019 , 08:00 AET
Queensland , Australia
Industry conference
09 Aug 2019 , 08:00 GMT
London , UK
Industry conference
Request a live demo
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
How can we help you?
Our team is always happy to hear from you. Please call us at:
Pharma Report Store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
Keep up to date